Potential application of titanium dioxide nanoparticles in the prevention of osteosarcoma and chondrosarcoma recurrence

Journal of Nanoscience and Nanotechnology

Volumn 13, Issue 2, 2013, Pages 1208-1211

  Sha, Baoyong ^a   Gao, Wei ^a   Han, Yulong ^a   Wang, Shu Qi ^b   Wu, Jinhui ^c   Xu, Feng ^a   Lu, Tian Jian ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NANJING UNIVERSITY   (China)

Author keywords

Chondrosarcoma; Osteosarcoma; Titanium dioxide (TiO2) nanoparticles

Indexed keywords

CHONDROSARCOMA; INHIBITORY CONCENTRATION; NANOPARTICLE (NPS); OSTEOSARCOMA; REACTIVE OXYGEN SPECIES; TIO; TITANIUM DIOXIDE NANOPARTICLES; TREATMENT METHODS;

BONE; CELL CULTURE; CELL DEATH; NANOPARTICLES; OXIDES; PHOTOCATALYSIS; TUMORS;

TITANIUM DIOXIDE;

GLUTATHIONE; METAL NANOPARTICLE; REACTIVE OXYGEN METABOLITE; TITANIUM; TITANIUM DIOXIDE;

ARTICLE; CHEMISTRY; CHONDROSARCOMA; HUMAN; METABOLISM; OSTEOSARCOMA; PATHOLOGY; TUMOR RECURRENCE;

CHONDROSARCOMA; GLUTATHIONE; HUMANS; METAL NANOPARTICLES; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; REACTIVE OXYGEN SPECIES; TITANIUM;

MLCS; MLOWN;

EID: 84876264538     PISSN: 15334880     EISSN: 15334899     Source Type: Journal    
DOI: 10.1166/jnn.2013.6081     Document Type: Conference Paper

References (16)

1. A. J. Chou, P. R. Merola, L. H. Wexler, R. G. Gorlick, Y. M. Vyas, J. H. Healey, M. P. LaQuaglia, A. G. Huvos, and P. A. Meyers, Cancer 104, 2214 (2005).
2. L. Jeys, M. David, and R. Grimer, J. Bone. Joint. Surg. 92-B, 65 (2008).
3. E. Nystrom, K. E. Kahnberg, and T. Albrektsson, Int. J. Oral. Max. Impl. 8, 167 (1993).
4. K. D. Secinti, H. Ozalp, A. Attar, and M. F. Sargon, J. Clin. Neurosci. 18, 391 (2011).
5. I. Nishimura, Y. Huang, F. Butz, T. Ogawa, A. Lin, and C. J. Wang, Nanotechnology 18, 245101 (2007).
6. Y. H. Tsuang, J. S. Sun, Y. C. Huang, C. H. Lu, W. H. S. Chang, and C. C. Wang, Artif Organs. 32, 167 (2008).
7. T. Mosmann, J. Immunol. Methods 65, 55 (1983).
8. J. Zhan and P. Zhou, Toxicology 186, 119 (2003).
9. B. Y. Sha, W. Gao, Q. S. Wang, F. Xu, and T. J. Lu, Compos. Part B: Eng. 42, 2136 (2011).
10. H. Yin, P. S. Casey, and M. J. McCall, J. Nanosci. Nanotechnol. 10, 7565 (2010).
11. L. F. Qi, Z. R. Xu, and M. L. Chen, Eur. J. Cancer. 43, 184 (2007).
12. L. Gonzalez, D. Lison, and M. Kirsch-Volders, Nanotoxicology 2, 252 (2008).
13. T. Finkel and N. J. Holbrook, Nature 408, 239 (2000).
14. F. Xu, J. H. Wu, S. Q. Wang, N. G. Durmus, U. A. Gurkan, and U. Demirci, Biofabrication 3, 034101 (2011).
15. L. H. Zhou, G. Y. Huang, S. Q. Wang, J.H Wu, W. G. Lee, Y. M. Chen, F. Xu, and T. J. Lu, Biotechnol. J. DOI 10.1002/biot.201100098 (2011).
16. F. Xu, C. M. Wu, V. Rengarajan, T. D. Finley, H. O. Keles, Y. Sung, B. Li, U. A. Gurkan, and U. Demirci, Adv. Mater. 23, 4254 (2011).